Comparison of short- and long-term outcomes between laparoscopic and open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy: a propensity score matching analysis

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Current status of diagnosis and treatment of early gastric cancer in China—data from China Gastrointestinal Cancer Surgery Union Zhonghua Wei Chang Wai Ke Za Zhi 21 168-174

[3] Siegel RL(2016)Gastric cancer The Lancet 388 2654-2664

[4] Laversanne M(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20

[5] Soerjomataram I(2018)Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials Int J Surg 51 120-127

[6] Jemal A(2019)Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial The Lancet 393 1948-1957

[7] Bray F(2021)Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial Lancet Oncol 22 1081-1092

[8] Wang YLZ(2016)Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v38-v49

[9] Shan F(2021)The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021 Cancer Commun 41 747-795

[10] Van Cutsem E(1994)Laparoscopy-assisted Billroth-I gastrectomy Surg Laparosc Endosc 4 146-148

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Current status of diagnosis and treatment of early gastric cancer in China—data from China Gastrointestinal Cancer Surgery Union Zhonghua Wei Chang Wai Ke Za Zhi 21 168-174

[3] Siegel RL(2016)Gastric cancer The Lancet 388 2654-2664

[4] Laversanne M(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20

[5] Soerjomataram I(2018)Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials Int J Surg 51 120-127

[6] Jemal A(2019)Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial The Lancet 393 1948-1957

[7] Bray F(2021)Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial Lancet Oncol 22 1081-1092

[8] Wang YLZ(2016)Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v38-v49

[9] Shan F(2021)The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021 Cancer Commun 41 747-795

[10] Van Cutsem E(1994)Laparoscopy-assisted Billroth-I gastrectomy Surg Laparosc Endosc 4 146-148